Uripan XR

Indication :

Adults Uripan XR is indicated in adults for the symptomatic treatment of urge incontinence and/or increased urinary frequency associated with urgency as may occur in patients with unstable bladder. Paediatric population Uripan XR is indicated in children over 5 years of age for: - Urinary incontinence, urgency and frequency in unstable bladder conditions due to idiopathic overactive bladder or neurogenic bladder disorders (detrusor overactivity). - Nocturnal enuresis associated with detrusor overactivity, in conjunction with nondrug therapy, when other treatment has failed.

Composition :

Each extended release film coated tablet contains 10 mg of oxybutynin hydrochloride Excipient: Lactose monohydrate (flowlac 80), Povidone K30, Hypromellose (Methocel K15 M), Magnesium Stearate, Methocel E15, Polyethylene glycol 6000, Titanium Dioxide, Talc Purified.